[Imaging in structural heart disease : Impact on interventional therapy].

Area of Science:

• Cardiology
• Medical Imaging
• Interventional Cardiology

Background:

• Current catheterization laboratory treatments for structural heart disease include MitraClip® for mitral regurgitation, transcatheter aortic valve implantation (TAVI), patent foramen ovale (PFO) closure, and left atrial appendage (LAA) occlusion.
• These interventions rely heavily on precise diagnosis from modern cardiac imaging for treatment recommendations.

Purpose of the Study:

• To provide an overview of clinically utilized procedures in the catheterization laboratory for structural heart disease.
• To highlight the indispensable role of cardiac imaging in diagnosing structural heart disease and guiding interventional procedures.
• To emphasize the safety and efficacy enhancements offered by cardiac imaging during invasive treatments.

Main Methods:

• Review of current clinical practices and imaging modalities used in structural heart interventions.
• Discussion of how cardiac imaging complements traditional methods like fluoroscopy and angiography.
• Focus on the application of imaging for procedural guidance and patient follow-up.

Main Results:

• Cardiac imaging provides essential diagnostic information for structural heart disease interventions.
• Enhanced soft tissue characterization by imaging improves procedural safety beyond fluoroscopy and angiography.
• Individualized patient follow-up is facilitated by detailed imaging data.

Conclusions:

• Modern cardiac imaging is fundamental for the diagnosis and treatment of structural heart disease.
• Imaging significantly enhances the safety and effectiveness of catheter-based interventions.
• The role of cardiac imaging extends to personalized post-procedure care and monitoring.